Publications by authors named "Luke Fischer"

Claim this Profile
S
Sex Differences in Associations of Lewy Body Disease with Alzheimer's Disease and Cognitive Decline.
Madeline Wood Alexander, D Luke Fischer, Lawren VandeVrede, Emma Nichols, Lei Yu

Ann Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers.
D Luke Fischer, Lea T Grinberg, Jared T Ahrendsen, Thomas G Beach, Kevin F Bieniek

Alzheimers Dement· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Val66Met polymorphism moderates associations between physical activity and neurocognitive outcomes in older adults.
Claire J Cadwallader, Anna M VandeBunte, D Luke Fischer, Coty Chen, Valentina E Diaz

Alzheimers Dement (N Y)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct subcellular localization of tau and alpha-synuclein in lewy body disease.
D Luke Fischer, Marissa Menard, Omar Z Abdelaziz, Nicholas M Kanaan, Virginia G Cobbs

Acta Neuropathol Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological correlation of cerebrospinal fluid alpha-synuclein seed amplification assay in a behavioral neurology autopsy cohort.
Niyatee Samudra, D Luke Fischer, Steven Lenio, Argentina Lario Lago, Peter A Ljubenkov

Alzheimers Dement· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Precision Medicine Approach to Dementia Care: Syndrome, Etiology, and Copathology.
D Luke Fischer, William W Seeley

Pract Neurol (Fort Wash Pa)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's disease.
D Luke Fischer, Peggy Auinger, John L Goudreau, Katrina L Paumier, Allyson Cole-Strauss

Front Neurol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in rats.
Natosha M Mercado, Jennifer A Stancati, Caryl E Sortwell, Rebecca L Mueller, Samuel A Boezwinkle, D Luke Fischer

Neurobiol Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease.
D Luke Fischer, Peggy Auinger, John L Goudreau, Allyson Cole-Strauss, Karl Kieburtz

Neurotherapeutics· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
Nenavath Gopal Naik, Thomas Hong Nguyen, Lauren Roberts, Luke Todd Fischer, Katherine Glickman

PLoS Pathog· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Ventricular Drain Placement Accuracy and Safety When Done by Midlevel Practitioners.
Nathaniel R Ellens, D Luke Fischer, Jason E Meldau, Brett A Schroeder, Sanjay E Patra

Neurosurgery· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BDNF provides many routes toward STN DBS-mediated disease modification.
D Luke Fischer, Caryl E Sortwell

Mov Disord· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson's Disease.
Megan F Duffy, Timothy J Collier, Joseph R Patterson, Christopher J Kemp, D Luke Fischer

Front Neurosci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bdnf variant is associated with milder motor symptom severity in early-stage Parkinson's disease.
D Luke Fischer, Peggy Auinger, John L Goudreau, Katrina L Paumier, Allyson Cole-Strauss

Parkinsonism Relat Disord· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.
Megan F Duffy, Timothy J Collier, Joseph R Patterson, Christopher J Kemp, Kelvin C Luk, D Luke Fischer

J Neuroinflammation· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.
Megan F Duffy, Timothy J Collier, Joseph R Patterson, Christopher J Kemp, Kelvin C Luk, D Luke Fischer

J Neuroinflammation· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESTIMATING SHAPE CORRESPONDENCE FOR POPULATIONS OF OBJECTS WITH COMPLEX TOPOLOGY.
James Fishbaugh, Laura Pascal, Luke Fischer, Tung Nguyen, Celso Boen

Proc IEEE Int Symp Biomed Imaging· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can STN DBS protect both nigral somata and innervation of the striatum?
D Luke Fischer, Fredric P Manfredsson, Caryl E Sortwell

Ann Neurol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subthalamic Nucleus Deep Brain Stimulation Does Not Modify the Functional Deficits or Axonopathy Induced by Nigrostriatal α-Synuclein Overexpression.
D Luke Fischer, Fredric P Manfredsson, Christopher J Kemp, Allyson Cole-Strauss, Jack W Lipton

Sci Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-Synuclein mRNA Is Not Increased in Sporadic PD and Alpha-Synuclein Accumulation Does Not Block GDNF Signaling in Parkinson's Disease and Disease Models.
Xiaomin Su, D Luke Fischer, Xin Li, Krystof Bankiewicz, Caryl E Sortwell

Mol Ther· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subthalamic Nucleus Deep Brain Stimulation Employs trkB Signaling for Neuroprotection and Functional Restoration.
D Luke Fischer, Christopher J Kemp, Allyson Cole-Strauss, Nicole K Polinski, Katrina L Paumier

J Neurosci· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age and vector construct on striatal and nigral transgene expression.
Nicole K Polinski, Fredric P Manfredsson, Matthew J Benskey, D Luke Fischer, Christopher J Kemp

Mol Ther Methods Clin Dev· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral Vector-Based Modeling of Neurodegenerative Disorders: Parkinson's Disease.
D Luke Fischer, Sara E Gombash, Christopher J Kemp, Fredric P Manfredsson, Nicole K Polinski

Methods Mol Biol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine.
D Luke Fischer, Timothy J Collier, Allyson Cole-Strauss, Susan L Wohlgenant, Jack W Lipton

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis